Drug Eluting Balloon Market

Growing segment fueling the growth of Drug Eluting Balloon Market


The global Drug Eluting Balloon Market is estimated to be valued at US$ 667.78 Mn in 2023 and is expected to exhibit a CAGR of 8.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:-

Drug eluting balloons are medical devices coated with antiproliferative (cell growth-inhibiting) drugs. They are used to prevent reblockage of arteries during balloon angioplasty. Drug eluting balloons minimize tissue trauma and deliver drugs to treat narrowed or blocked arteries.

Market key trends:-

Increasing prevalence of peripheral artery disease is expected to drive the growth of the drug eluting balloon market over the forecast period. Peripheral artery disease occurs when arteries other than the heart arteries become narrowed or blocked, preventing an adequate blood flow to the limbs and other organs. It is estimated that over 8.5 million Americans are affected by peripheral artery disease. Expanding aging population and rising lifestyle diseases such as obesity and diabetes are risk factors for peripheral artery disease, fueling the demand for treatment options like drug eluting balloons.

Segment Analysis:-

The global drug eluting balloon market can be segmented based on material, disease indication, end user and geography. The paclitaxel eluting balloons segment dominates the market and accounts for the largest revenue share. Paclitaxel is one of the most effective drugs used for coating balloons. Its anti-proliferative and anti-inflammatory properties help in preventing restenosis.

Key Takeaways:-

The Global Drug Eluting Balloon Market Demand is expected to witness high growth, exhibiting a CAGR of 8.3% over the forecast period, due to increasing prevalence of cardiovascular diseases.

Regional analysis:-

North America dominates the global market and is expected to continue its dominance over the forecast period. Higher adoption of advanced technology, growing elderly population, and rising incidence of CVDs are some major factors driving the growth of drug eluting balloon market in the region.

Key players:-

Key players operating in the drug eluting balloon market are Medtronic, Becton Dickinson and Company (BD), Boston Scientific Corporation, Cook Medical, B. Braun Melsungen AG, Koninklijke Philips N.V., Opto Circuits (India) Limited, Terumo Corporation, Surmodics, Inc., and Biotronik. Medtronic dominates the market owing to its robust product portfolio and strong geographic presence across the globe.

1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it